浏览全部资源
扫码关注微信
清华大学医学院 北京 100084
Published:20 January 2018,
Received:21 July 2017,
Revised:16 August 2017,
扫 描 看 全 文
Liu Xin-yu, Hu Jin, Guo Jian-wen, Wang Gui-lin, Gao Wei-ping. Temperature-responsive Polymer Conjugation of Interferon-
Liu Xin-yu, Hu Jin, Guo Jian-wen, Wang Gui-lin, Gao Wei-ping. Temperature-responsive Polymer Conjugation of Interferon-
利用定点原位生长技术,合成了一种温度响应性的干扰素-聚(2-甲基-2-丙烯酸-2-(2-甲氧基乙氧基)乙酯)偶联物(IFN-PDEGMA).当温度低于22℃时,IFN-PDEGMA处于溶解状态;当温度高于22℃时,IFN-PDEGMA则会发生聚集.由于小鼠体温高于22℃,因此,将IFN-PDEGMA原位注射到小鼠肿瘤组织处之后,它会在肿瘤组织处聚集驻留.体外实验结果显示,IFN-PDEGMA有效保持了干扰素的结构和活性;动物实验结果显示,相比于原药IFN-
α
,非温敏性IFN-POEGMA、商业化的长效干扰素PEGASYS以及IFN-PDEGMA可以更好地聚集驻留在肿瘤处,荷黑色素瘤小鼠的生存时间得以显著延长,分子量为10 kDa、30 kDa、60 kDa、100 kDa的IFN-PDEGMA所治疗的小鼠,其生存时间分别为36.5、31、29.5、28天,其中,10 kDa和30 kDa的IFN-PDEGMA的治疗效果均要优于PEGASYS.同时,生物安全性实验显示IFN-PDEGMA对正常组织器官不存在显著的毒副作用.
Interferon-
α
(IFN) has a short circulating half-life
which not only leads to limited clinical efficacy
but also causes severe side effects and poor patient compliance. Previously
we developed ELPfusion and site-specific
in situ
growth (SIG) methods to prolong the half-life of IFN
while the adopted intravenous administration still could not well concentrate IFN inside tumour tissues. In order to enhance the tumour accumulation and antitumour efficacy of IFN
in this study
we report intratumoural administration of temperature responsive interferon-poly(di(ethylene glycol) methyl ether methacrylate) conjugates (IFN-PDEGMA). First
we employed SIG method to synthesize a series of temperature responsive IFN-PDEGMAs with different molecular weights (10 kDa
30 kDa
60 kDa and 100 kDa). The preparation process was monitored by SDS-PAGE
and the molecular weights
hydrodynamic radius and secondary structures of conjugates were characterized by GPC
DLS and CD (circular dichroism)
respectively. The phase transition temperatures were determined to be around 22℃. Thus
IFN-PDEGMA were soluble below 22℃; and they became insoluble above 22℃. Since the body temperature of mice is above 22℃
IFN-PDEGMA injected into the tumour tissue of mice aggregated locally and became a drug depot in the tumour.
In vitro
characterization demonstrated that the structure and anti-proliferative activity of IFN were well remained for IFN-PDEGMA.
In vivo
experiments showed that the survival time of A375 melanoma-bearing mice were well extended by IFN-PDEGMA treatment compared with IFN-
α
. To be specific
the survival times of mice treated by IFN-PDEGMA of 10 kDa
30 kDa
60 kDa and 100 kDa were 36.5
31
29.5 and 28 days
respectively. IFN-PDEGMA of 10 kDa and 30 kDa both exhibited better anti-melanoma efficacy than commercial long-acting interferon
PEGASYS. Meanwhile
the biological safety experiments also showed that IFN-PDEGMA treatment did not have obvious side effects on normal tissues. In summary
we
for the first time
reported intratumoural administration of temperature responsive IFN-PDEGMA and studied the rule about how the molecular weight impacts on their properties
in vitro
and
in vivo
. This study not merely displayed an instance of temperature responsive protein-polymer conjugates and their anti-tumour efficacy
but also provided inspiration to further build a series of smart protein-polymer conjugates and seek for their potential applications in the diagnosis and treatment of major diseases such as cancer
virosis
diabetes and cardiovascular disease.
干扰素蛋白质-高分子偶联物原子转移自由基聚合药物递送温度响应
InterferonProtein-polymer conjugateAtom transfer radical polymerizationDrug deliveryTemperature responsiveness
B Leader , Q J Baca , D E Golan . Nat Rev Drug Discov , 2008 . 7 21 - 39 . DOI:10.1038/nrd2399http://doi.org/10.1038/nrd2399.
G Walsh . Nat Biotechnol , 2010 . 28 917 - 924 . DOI:10.1038/nbt0910-917http://doi.org/10.1038/nbt0910-917.
L M Pfeffer , C A Dinarello , R B Herberman , B R G Williams , E C Borden , R Bordens , M R Walter , T L Nagabhushan , P P Trotta , S Pestka . Cancer Res , 1998 . 58 2489 - 2499.
R J Wills . Clin Pharmacokinet , 1990 . 19 390 - 399 . DOI:10.2165/00003088-199019050-00003http://doi.org/10.2165/00003088-199019050-00003.
M J Roberts , M D Bentley , J M Harris . Adv Drug Deliver Rev , 2002 . 54 459 - 476 . DOI:10.1016/S0169-409X(02)00022-4http://doi.org/10.1016/S0169-409X(02)00022-4.
G M Subramanian , M Fiscella , A Lamouse , S Zeuzem , J G McHutchison . Nat Biotechnol , 2007 . 25 1411 - 1419 . DOI:10.1038/nbt1364http://doi.org/10.1038/nbt1364.
S Zeuzem , S V Feinman , J Rasenack , E J Heathcote , M Y Lai , E Gane , J O'Grady , J Reichen , M Diago , A Lin , J Hoffman , M J Brunda . New Engl J Med , 2000 . 343 1666 - 1672 . DOI:10.1056/NEJM200012073432301http://doi.org/10.1056/NEJM200012073432301.
E J Heathcote , M L Shiffman , M G E Cooksley , G M Dusheiko , S S Lee , L Balart , R Reindollar , R K Reddy , T L Wright , A Lin , J Hoffman , J Pamphilis . New Engl J Med , 2000 . 343 1673 - 1680 . DOI:10.1056/NEJM200012073432302http://doi.org/10.1056/NEJM200012073432302.
F M Veronese . Biomaterials , 2001 . 22 405 - 417 . DOI:10.1016/S0142-9612(00)00193-9http://doi.org/10.1016/S0142-9612(00)00193-9.
S Foser , A Schacher , K A Weyer , D Brugger , E Dietel , S Marti , T Schreitmuller . Protein Expres Purif , 2003 . 30 78 - 87 . DOI:10.1016/S1046-5928(03)00055-Xhttp://doi.org/10.1016/S1046-5928(03)00055-X.
Y S Wang , S Youngster , M Grace , J Bausch , R Bordens , D F Wyss . Adv Drug Deliver Rev , 2002 . 54 547 - 570.
S Zeuzein , E M Yoshida , Y Benhamou , S Pianko , V G Bain , D Shouval , R Flisiak , V Rehak , M Grigorescu , K Kaita , P W Cronin , E Pulkstenis , G M Subramanian , J G McHutchison . Hepatology , 2008 . 48 407 - 417.
Y S Huang , Z Chen , Z Y Yang , T Y Wang , L Zhou , J B Wu , L F Zhou . Eur J Pharm Biopharm , 2007 . 67 301 - 308 . DOI:10.1016/j.ejpb.2007.02.015http://doi.org/10.1016/j.ejpb.2007.02.015.
J Hu , G Wang , X Liu , W Gao . Adv Mater , 2015 . 27 7320 - 7324 . DOI:10.1002/adma.201503440http://doi.org/10.1002/adma.201503440.
J Hu , G Wang , W Zhao , X Liu , L Zhang , W Gao . Biomaterials , 2016 . 96 84 - 92 . DOI:10.1016/j.biomaterials.2016.04.035http://doi.org/10.1016/j.biomaterials.2016.04.035.
J Hu , G Wang , W Zhao , W Gao . J Control Release , 2016 . 237 71 - 77 . DOI:10.1016/j.jconrel.2016.07.007http://doi.org/10.1016/j.jconrel.2016.07.007.
P De , M Li , S R Gondi . J Am Chem Soc , 2008 . 130 11288 - 11289 . DOI:10.1021/ja804495vhttp://doi.org/10.1021/ja804495v.
A Chilkoti , G Chen , P S Stayton , A S Hoffman . Bioconjug Chem , 1994 . 5 504 - 507 . DOI:10.1021/bc00030a004http://doi.org/10.1021/bc00030a004.
A S Hoffman , P S Stayton . Prog Polym Sci , 2007 . 32 922 - 932 . DOI:10.1016/j.progpolymsci.2007.05.005http://doi.org/10.1016/j.progpolymsci.2007.05.005.
X Liu , W Gao . ACS Appl Mater Interfaces , 2017 . 9 2023 - 2028 . DOI:10.1021/acsami.6b14132http://doi.org/10.1021/acsami.6b14132.
J F Lutz , A Hoth . Macromolecules , 2006 . 39 893 - 896 . DOI:10.1021/ma0517042http://doi.org/10.1021/ma0517042.
J F Lutz , Ö Akdemir , A Hoth . J Am Chem Soc , 2006 . 128 13046 - 13047 . DOI:10.1021/ja065324nhttp://doi.org/10.1021/ja065324n.
Yi Guo , Hengjiang Liu , Jieqiong Chen , Yazhuo Shang , Honglai Liu . Acta Phys-Chim Sin , 2015 . ( 31 ): 1914 - 1923 . http://kns.cnki.net/KCMS/detail/detail.aspx?filename=wlhx201510011&dbname=CJFD&dbcode=CJFQ.
郭 奕 , 刘 恒江 , 陈 洁琼 , 尚 亚卓 , 刘 洪来 . 物理化学学报 , 2015 . ( 31 ): 1914 - 1923 . http://kns.cnki.net/KCMS/detail/detail.aspx?filename=wlhx201510011&dbname=CJFD&dbcode=CJFQ.
Z Zarafshani , T Obata , J F Lutz . Biomacromolecules , 2010 . 11 2130 - 2135 . DOI:10.1021/bm1005036http://doi.org/10.1021/bm1005036.
Qisheng Fang , Tao Chen , Qiushi You , Danni Yu , Jiping Wang . Acta Polymerica Sinica , 2016 . ( 5 ): 637 - 644 . http://www.gfzxb.org/CN/abstract/abstract14567.shtml.
方 奇生 , 陈 涛 , 游 秋实 , 余 丹妮 , 王 际平 . 高分子学报 , 2016 . ( 5 ): 637 - 644 . http://www.gfzxb.org/CN/abstract/abstract14567.shtml.
0
Views
11
下载量
3
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution